Sunday, 17 February 2019


GENERAL: AFT: AFT painkiller Maxigesic now licensed in Mexico

27 Dec 2017 08:30NZX
Market release
27 December 2017

AFT Pharmaceuticals'' painkiller Maxigesic now licensed in first North
American market, Mexico, taking licensed countries to 125.

AFT Pharmaceuticals (''AFT'') has extended its existing agreements to add the
Mexican company, Laboratories Expanscience Mexico SA (''Expanscience Mexico'')
to out-license the product line of its patented combination painkiller,
Maxigesic, to Mexico.

Expanscience Mexico is a wholly owned subsidiary of privately-owned French
pharmaceutical company, Laboratoires Expanscience S.A. (''Expanscience'') which
already holds Maxigesic rights for France.

Maxigesic consists of a patented, fixed ratio of ibuprofen for
anti-inflammation management and paracetamol (also called acetaminophen) for
pain management. Maxigesic products covered by the new licensing agreement
include tablet, oral liquid, fast-dissolve and dry powder sachets.

AFT Managing Director, Dr Hartley Atkinson, says that he is very pleased to
further extend the company''s partnership with Expanscience.

"We had previously disclosed our target to sell Maxigesic to 100 countries in
the disclosure statement. As a result of this latest partnership with
Expanscience, we have now further increased our agreements to some 125
countries. Importantly we''ve now added our first market in North America.
Mexico is the fifteenth largest market in the world for sales of Paracetamol
tablets and of Ibuprofen oral tablets."

"Although we will need to complete product registrations in Mexico in the
near future, we anticipate sales to commence within the FY19 time period. As
previously noted, we have experienced some delays in launches due to
regulatory delays in various countries, but the number of Maxigesic launches
to occur within the FY19 time period is increasing with over 30 new launches

We believe that Mexico represents good potential for Maxigesic as the market
defined by IMS Health for paracetamol tablet and ibuprofen tablet sales in
Mexico is close to an aggregate of US$200M."

Ferghana Partners (New York, London, Boston) initiated these transactions and
provided strategic/financial advisory services to AFT Pharma.

About Expanscience Mexico SA
Laboratorios Expanscience Mexico, S.A. DE C.V., a company incorporated in
Mexico and having its registered office at Blvd Miguel Cervantes de Saavedra
233, Colonia Grenada, C.P. 11520 Mexico and wholly owned subsidiary of
Laboratoires Expanscience is a pharmaceutical company incorporated in France
having its registered office at 1 Place des Saisons 92048 Paris La Defense
Cedex, Paris, France

End of release
For more information:
Hartley Atkinson
Managing Director, AFT Pharmaceuticals Ltd
Phone +64 9 488 0232
End CA:00312455 For:AFT    Type:GENERAL    Time:2017-12-27 08:30:19
Views: 201
AFT Pharmaceuticals Limited
 2.600 Change:
Last Traded:07/02/18 09:10:21 
52-Wk High:2.900 
52-Wk Low:2.160